Found 5 matching trials
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
PHASE3The purpose of this study is to determine whether once-nightly FT218 is saf...
Location
Pinnacle Research Group LLC
Extended-release Sodium Oxybate in Children
PHASE2The main objectives of this study are to determine the treatment preference...
Location
Stanford University
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
PHASE1Using a comprehensive approach of clinico-behavioral testing and neuroimagi...
Location
Massachusetts Eye and Ear
An Open Label Study of FT218 in Subjects With Narcolepsy
PHASE3An Open Label Study to Evaluate Long-Term Safety and Tolerability of a Once...
Location
Sleep Disorders Center of Alabama
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
PHASE3This is a double-blind, placebo-controlled, randomized withdrawal, multicen...
Location
Alpine Clinical Research Center